2] Relatively recent studies have shown that human melanoma and breast cancer cells can induce bone resorption in a murine calvaria culture system through both the direct elaboration of interleukin 11
(IL-11) and by enhancing its production via the activation of the latent transforming growth factor [Beta] (TGF-[Beta])[3,4]; therefore, it was hypothesized that these 2 cytokines may be involved in the pathogenesis of the osteolytic lesions in LCH.
Genetics Institute is also conducting Phase 3 clinical trials for Neumega(TM) (recombinant human interleukin 11
, rhIL-11), a protein for treating or preventing low platelet levels in patients undergoing intensive cancer chemotherapy treatments.
NASDAQ: GENIZ) announced today that it has licensed Japanese development and marketing rights for recombinant human interleukin 11
(rhIL-11) to GI-Yamanouchi, Inc.